ARCHIMED Japan — 2014 Investments

2 investments dated 2014 · listed companies and verified rows first · show all

Esperion Therapeuticsesperion.comJun 2014

Biopharma developing HDL-C regulating therapies; listed 2000.

BiotechAnn Arbor, US

Roger S. Newton(Director)inTim M. Mayleben(Executive Officer, Director)

BoardDaniel Janney(Director)Dov A. Goldstein(Director)Nicole Vitullo(Director)in Patrick Enright(Director)in

Co-investorsAisling Capital Alta Partners Arboretum Ventures Asset Management Company Canaan Partners HealthCap +3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Pyxant Labs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.